Help your eligible patients save on LOTEMAX GEL

PATIENT SAVINGS

Eligible Commercially Insured Patients May Pay as Little as a $25 Copay^†

Special Savings Offer: Eligible commercially insured patients may pay as little as a $25^† copay for 1st prescription and eligible refills. Discounted pricing is also available for eligible uninsured patients. ^†

To help eligible patients save, visit the link below to access web coupons or contact your sales representative to provide printed coupons in-office.

ENSURE YOUR PATIENTS ACTIVATE THEIR COUPON

ACTIVATE: To activate the print coupon, call 1-866-693-4880.

To activate the online Web coupon, visit www.bauschaccessprogram.com and follow the instructions.

Bausch + Lomb has aligned with Walgreens to stock product and help eligible patients redeem special prescription savings on LOTEMAX GEL.

If you have any questions regarding the program, please call 1-866-693-4880.

^†Terms, Conditions and Limitations apply. Please see www.bauschaccessprogram.com and www.lotemaxgelpartdcoupon.com for eligibility criteria and terms and conditions.

Most Eligible Medicare Part D Patients Pay No More Than $60 Copay^†

Medicare Part D Insured Patients

Most eligible patients PAY NO MORE THAN $60^† on each LOTEMAX GEL prescription.

ENSURE YOUR eligible PATIENT ACTIVATES THEIR COUPON

ACTIVATE: To activate the print coupon, call 1-866-695-9604. Web coupon is automatically activated once patient agrees to statements on www.lotemaxgelpartdcoupon.com to download coupon.
REDEEM: Redeem the coupon card at a participating retail pharmacy with prescription and insurance card.
MAIL: Sign and mail the prewritten letter to health plan, which notifies the health plan of their choice to use the benefits of this program. Health care plan address can be found on the Medicare provider card.

To help patients save, visit the link below to access web coupons or contact your sales representative to provide printed coupons in-office.

If you have questions related to this program,
please call 1-866-685-9605.

^†Terms, Conditions and Limitations apply. Please see www.bauschaccessprogram.com and www.lotemaxgelpartdcoupon.com
for eligibility criteria and terms and conditions.

INDICATION

LOTEMAX^® GEL (loteprednol etabonate ophthalmic gel) 0.5% is indicated for the treatment of post-operative inflammation and pain following ocular surgery.

Important Safety Information

LOTEMAX^® GEL is contraindicated in most viral diseases of the cornea and conjunctiva including epithelial herpes simplex keratitis (dendritic keratitis), vaccinia, and varicella, and also in mycobacterial infection of the eye and fungal diseases of ocular structures.
Prolonged use of corticosteroids, including LOTEMAX, may result in glaucoma with damage to the optic nerve, defects in visual acuity and fields of vision. Steroids should be used with caution in the presence of glaucoma. If this product is used for 10 days or longer, IOP should be monitored.
Use of corticosteroids may result in posterior subcapsular cataract formation.
The use of steroids after cataract surgery may delay healing and increase the incidence of bleb formation. In those diseases causing thinning of the cornea or sclera, perforations have been known to occur with the use of topical steroids. The initial prescription and renewal of the medication order should be made by a physician only after examination of the patient with the aid of magnification, and where appropriate, fluorescein staining.
Prolonged use of corticosteroids may suppress the host response and thus increase the hazard of secondary ocular infection. In acute purulent conditions, steroids may mask infection or enhance existing infections.
Employment of a corticosteroid medication in the treatment of patients with a history of herpes simplex requires great caution. Use of ocular steroids may prolong the course and may exacerbate the severity of many viral infections of the eye (including herpes simplex).
Fungal infections of the cornea are particularly prone to develop coincidentally with long-term local steroid application. Fungus invasion must be considered in any persistent corneal ulceration where a steroid has been used or is in use. Fungal cultures should be taken when appropriate.
Patients should not wear contact lenses during their course of therapy with LOTEMAX^® GEL.
The most common adverse drug reactions reported in the clinical trials (2-5%) were anterior chamber inflammation, eye pain, and foreign body sensation.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

Please see Prescribing Information for LOTEMAX^®GEL click here for Prescribing Information

LGX.0023.USA.20

All information and materials on this site pertain to the U.S. only, unless otherwise indicated.

CALIFORNIA RESIDENTS: DO NOT SELL MY PERSONAL INFORMATION

INDICATION

LOTEMAX^® GEL (loteprednol etabonate ophthalmic gel) 0.5% is indicated for the treatment of post-operative inflammation and pain following ocular surgery.

Important Safety Information

LOTEMAX^® GEL is contraindicated in most viral diseases of the cornea and conjunctiva including epithelial herpes simplex keratitis (dendritic keratitis), vaccinia, and varicella, and also in mycobacterial infection of the eye and fungal diseases of ocular structures.
Prolonged use of corticosteroids, including LOTEMAX, may result in glaucoma with damage to the optic nerve, defects in visual acuity and fields of vision. Steroids should be used with caution in the presence of glaucoma. If this product is used for 10 days or longer, IOP should be monitored.
Use of corticosteroids may result in posterior subcapsular cataract formation.
The use of steroids after cataract surgery may delay healing and increase the incidence of bleb formation. In those diseases causing thinning of the cornea or sclera, perforations have been known to occur with the use of topical steroids. The initial prescription and renewal of the medication order should be made by a physician only after examination of the patient with the aid of magnification, and where appropriate, fluorescein staining.
Prolonged use of corticosteroids may suppress the host response and thus increase the hazard of secondary ocular infection. In acute purulent conditions, steroids may mask infection or enhance existing infections.
Employment of a corticosteroid medication in the treatment of patients with a history of herpes simplex requires great caution. Use of ocular steroids may prolong the course and may exacerbate the severity of many viral infections of the eye (including herpes simplex).
Fungal infections of the cornea are particularly prone to develop coincidentally with long-term local steroid application. Fungus invasion must be considered in any persistent corneal ulceration where a steroid has been used or is in use. Fungal cultures should be taken when appropriate.
Patients should not wear contact lenses during their course of therapy with LOTEMAX^® GEL.
The most common adverse drug reactions reported in the clinical trials (2-5%) were anterior chamber inflammation, eye pain, and foreign body sensation.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

Please see Prescribing Information for LOTEMAX^®GEL click here for Prescribing Information

LGX.0016.USA.20

Help your eligible patients save on LOTEMAX GEL

PATIENT SAVINGS

Eligible Commercially Insured Patients May Pay as Little as a $25 Copay†

Most Eligible Medicare Part D Patients Pay No More Than $60 Copay†

INDICATION

Important Safety Information

INDICATION

Important Safety Information

Eligible Commercially Insured Patients May Pay as Little as a $25 Copay^†

Most Eligible Medicare Part D Patients Pay No More Than $60 Copay^†